FI870810A0 - Aminosyraderivater. - Google Patents

Aminosyraderivater.

Info

Publication number
FI870810A0
FI870810A0 FI870810A FI870810A FI870810A0 FI 870810 A0 FI870810 A0 FI 870810A0 FI 870810 A FI870810 A FI 870810A FI 870810 A FI870810 A FI 870810A FI 870810 A0 FI870810 A0 FI 870810A0
Authority
FI
Finland
Prior art keywords
aminosyraderivater
carboxytetrahydropyrid
carboxymethylpyrrolidin
carboxypiperidin
aminobut
Prior art date
Application number
FI870810A
Other languages
English (en)
Other versions
FI89355B (fi
FI870810A (fi
FI89355C (fi
Inventor
Frederik Christian Gronvald
Claus Braestrup
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI870810A publication Critical patent/FI870810A/fi
Publication of FI870810A0 publication Critical patent/FI870810A0/fi
Publication of FI89355B publication Critical patent/FI89355B/fi
Application granted granted Critical
Publication of FI89355C publication Critical patent/FI89355C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
FI870810A 1985-06-26 1987-02-25 Foerfarande foer framstaellning av terapeutiskt aktiva 1-aminobut-3-en-foereningar FI89355C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK288385 1985-06-26
DK288385A DK288385D0 (da) 1985-06-26 1985-06-26 Aminosyrederivater
DK8600076 1986-06-26
PCT/DK1986/000076 WO1987000171A1 (en) 1985-06-26 1986-06-26 Amino acid derivatives

Publications (4)

Publication Number Publication Date
FI870810A FI870810A (fi) 1987-02-25
FI870810A0 true FI870810A0 (fi) 1987-02-25
FI89355B FI89355B (fi) 1993-06-15
FI89355C FI89355C (fi) 1993-09-27

Family

ID=8116767

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870810A FI89355C (fi) 1985-06-26 1987-02-25 Foerfarande foer framstaellning av terapeutiskt aktiva 1-aminobut-3-en-foereningar

Country Status (16)

Country Link
US (1) US5010090A (fi)
EP (1) EP0236342B1 (fi)
JP (1) JPH07103116B2 (fi)
AT (1) ATE67196T1 (fi)
AU (1) AU599326B2 (fi)
CA (1) CA1284503C (fi)
DK (2) DK288385D0 (fi)
ES (1) ES8800927A1 (fi)
FI (1) FI89355C (fi)
GR (1) GR861650B (fi)
IE (1) IE59084B1 (fi)
LU (1) LU90130I2 (fi)
NZ (1) NZ216657A (fi)
PT (1) PT82841B (fi)
WO (1) WO1987000171A1 (fi)
ZA (1) ZA864608B (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
TR199700873T1 (xx) * 1995-02-28 1998-01-21 H. Lund-Beck A/S 4-Aminotetrahidrobenzizoksazol veya -izotiazol bile�ikleri.
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
JP3195360B2 (ja) * 1995-05-05 2001-08-06 ノボ ノルディスク アクティーゼルスカブ チアガビン塩酸塩を含有する医薬組成物およびその製法
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5958951A (en) * 1996-06-14 1999-09-28 Novo Nordiskials Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
EP0991409B1 (en) * 1997-08-01 2002-01-30 ELAN CORPORATION, Plc Controlled release pharmaceutical compositions containing tiagabine
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
US6503926B2 (en) * 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) * 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
DE19840611A1 (de) * 1998-09-05 2000-03-09 Klaus Wanner GABA-uptake-Inhibitoren mit Pyrrolidinstruktur
CA2361924A1 (en) * 1999-01-12 2000-07-20 Izumi Kamo Compositions for treating frequent urination and urinary incontinence
US6872734B2 (en) 2000-10-20 2005-03-29 Abbott Laboratories Use of tiagabine for treatment of diabetic neuropathy and migraine
IL155704A0 (en) 2000-11-30 2003-11-23 Pfizer Prod Inc Combination of gaba agonists and sorbitol dehydrogenase inhibitors
IL155710A0 (en) * 2000-11-30 2003-11-23 Pfizer Prod Inc Combination of gaba agonists and aldose reductase inhibitors
WO2002066456A2 (en) 2001-02-16 2002-08-29 Allelix Neuroscience, Inc. Thiophene substituted amine derivatives as glyt-1 inhibitors
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ－氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用
RU2005135454A (ru) * 2003-05-16 2006-06-27 Пфайзер Продактс Инк. (Us) Терапевтические комбинации атипичных нейролептиков с модуляторами гамк и/или противосудорожными препаратами
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
US7667042B2 (en) * 2003-12-24 2010-02-23 Sun Pharma Advanced Research Company Ltd. Stable polymorphic forms of an anticonvulsant
CN1314684C (zh) * 2003-12-24 2007-05-09 中国科学院上海有机化学研究所 噻加宾及其消旋体和s－构型的合成方法及其无定形粉末的制法
WO2005082372A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
WO2005092886A1 (en) * 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of tiagabine
WO2006013550A2 (en) * 2004-08-04 2006-02-09 Ranbaxy Laboratories Limited Process for preparation of piperidine carboxylic acid
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20080051435A1 (en) * 2006-08-18 2008-02-28 Cephalon, Inc. Crystalline and amorphous forms of tiagabine
US20080064727A1 (en) * 2006-08-18 2008-03-13 Cephalon, Inc. Crystalline forms of tiagabine hydrochloride
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20090082401A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched tiagabine
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN101857591B (zh) * 2009-04-09 2013-06-05 北京京卫燕康药物研究所有限公司 盐酸噻加宾晶型及其制备方法
CN102070624B (zh) * 2011-01-25 2013-04-10 赵学清 一种盐酸噻加宾的合成方法及无水盐酸噻加宾的制备方法
CN102827152B (zh) * 2012-09-17 2014-11-05 扬子江药业集团四川海蓉药业有限公司 噻加宾的制备方法及其前体化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
EP0231996B1 (en) * 1986-01-07 1993-10-06 Novo Nordisk A/S Novel amino acid derivatives

Also Published As

Publication number Publication date
LU90130I2 (fr) 1997-10-24
AU599326B2 (en) 1990-07-19
WO1987000171A1 (en) 1987-01-15
DK100887A (da) 1987-02-26
DK100887D0 (da) 1987-02-26
FI89355B (fi) 1993-06-15
FI870810A (fi) 1987-02-25
AU6133686A (en) 1987-01-30
FI89355C (fi) 1993-09-27
ES8800927A1 (es) 1987-12-01
US5010090A (en) 1991-04-23
IE59084B1 (en) 1994-01-12
JPH07103116B2 (ja) 1995-11-08
GR861650B (en) 1986-10-30
ZA864608B (en) 1987-02-25
PT82841A (en) 1986-07-01
EP0236342A1 (en) 1987-09-16
JPS62503172A (ja) 1987-12-17
DK156398C (da) 1990-01-08
CA1284503C (en) 1991-05-28
IE861702L (en) 1986-12-26
NZ216657A (en) 1989-10-27
EP0236342B1 (en) 1991-09-11
ES556659A0 (es) 1987-12-01
PT82841B (pt) 1989-01-17
DK156398B (da) 1989-08-14
DK288385D0 (da) 1985-06-26
ATE67196T1 (de) 1991-09-15

Similar Documents

Publication Publication Date Title
FI870810A0 (fi) Aminosyraderivater.
FI894095A0 (fi) Vaermare foer anvaendning i mikrovaogsugnar.
ATE74125T1 (de) Didehydro-vitamin d3-derivate.
DK330789A (da) Substituerede 1,7-annellerede 1 h-indazoler
NO891746L (no) Konserveringsmiddel.
DE58906490D1 (de) Schrankanordnung.
DE58907550D1 (de) Leistungsverstärker.
ES1014131Y (es) Armario surtidor.
NO890522D0 (no) Substituerte imidazolinoner og imidazolinthioner.
FI885145A0 (fi) Laddande spis foer nattelektricitet.
ATE87051T1 (de) Schranke.
ES1015902Y (es) Tapon perfeccionado.
ES1017217Y (es) Tapon perfeccionado.
ES1004056Y (es) Candado perfeccionado.
ES1003934Y (es) Candado perfeccionado.
IT8806807A0 (it) I legnetti
ES1018747Y (es) Tapon de cierre hermetico perfeccionado.
ES1007190Y (es) Nevera portatil perfeccionada.
ES1008693Y (es) Tapon perfeccionado.
ES1010376Y (es) Tapon perfeccionado.
ES1019194Y (es) Tapon precinto perfeccionado.
ES1006485Y (es) Columpio perfeccionado.
ES1019663Y (es) Frigorifico perfeccionado.
IT8819333A0 (it) 1,1 difluoroallil e 1,1difluoropropargil derivati.
NO884785D0 (no) Skap.

Legal Events

Date Code Title Description
BB Publication of examined application
NF Re-establishment of lapsed right
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L112

Extension date: 20110613

FG Patent granted

Owner name: NOVO NORDISK A/S

MA Patent expired